Welcome to YLOAN.COM
yloan.com » Medical » Stock Alert On Pwrm.ob ( Power 3 Medical) Presented By Pennytobuck.com
Health Medical Acne Aerobics-Cardio Alternative Anti-Aging Build-Muscle Chronic-Illness Dental-Care Depression Diabetes Disability Exercise Eye-Care Fitness-Equipment Hair-Loss Medicine Meditation Nutrition Obesity Polution Quit-Smoking Sidha Supplements Yeast Infection H1N1 Swine Flu SARS herpes therapy panic surgeon hurts teeth remedies eliminate chiropractic arthritis ingredients syndrome binding anxiety surgery medication psychic dental reflux doctor relief premature emotional stress disorder implants wrinkles vision infection aging liposuction seattle stunning sweating hair treatment tinnitus

Stock Alert On Pwrm.ob ( Power 3 Medical) Presented By Pennytobuck.com

Last Trade: 0.0390

Last Trade: 0.0390

Change: (-4.80%)

Bid: 0.0357 x 5000

Ask: 0.0370 x 5000

Volume: 226,225

Avg Vol (3m): 2,794,920

Power3 Medical Products, Inc. (OTC BB: PWRM.OB) strives to become the premier biotechnology company specializing in the commercialization of proteomics IP for the diagnosis and treatment of disease by using cutting edge technologies, world class quality procedures and superior research methodologies. The Company will be guided in all of its dealings with its customers, partners, shareholders, associates and investors by the philosophy of best practices.

Also on July 12 in Honolulu, Hawaii Power 3 will be presenting four abstracts to this annual meeting of the International Congress of Alzheimers Disease. The presentations will cover results from protein biomarker discovery, drug response, test development, and ongoing clinical validation trials of the NuroPro AD biomarkers and blood test for Alzheimers disease. The four studies to be presented involve a total of 154 Alzheimers disease patients and 91 Parkinsons disease patients, as well as 210 age-matched normal control individuals and 173 disease control individuals.

PWRM is a leading edge biotechnology company engaged in the early detection, monitoring, and targeting of diseases through the analysis of proteins. This dynamic team utilizes proteomics in the discovery of protein biomarkers, drug pathways, and mechanisms of disease.

2D gel image analysisResearch

PWRM uses technologies, know-how and proprietary techniques to focus on protein-based biomarkers, which are simply proteins that are significant in the diagnosis, monitoring or treatment of disease. For on-target treatment with new medicines the need is to identify and assess the disease-related proteins and the healthy-related proteins. Only by specifying the precise differences between disease-related and healthy-related proteins can the development of a new diagnostic test to detect the disease, and new drugs to treat the disease effectively be done.

PWRMs research platform dates back to 1975 when Chief Scientific Officer, Dr. Ira Goldknopf, made a startling and unprecedented discovery that would change the science of proteins; the ubiquitin conjugation of proteins, Protein Ubiquitination.

For more information about this company (PWRM) please visit http://www.power3medical.com

***********************************

For FREE Daily Stock Alerts & Updates Signup At: http://pennytobuck.com/signup


***********************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (read more ) Rule 17B requires disclosure of payment for investor relations.Crown Equity Holdings, Inc. (CRWE.OB) has previously received five hundred thousand shares compensation for 30 days of advertisement services and received an additional 1,000,000 shares 144 restricted stocks for a continuation of 6 months of advertisement and disseminating news, as well as $15,000 dollars for IR services for Power 3 Medical Products Inc. (PWRM.OB). Recently, Crown Equity Holdings, Inc has received an additional amount of 2,000,000 shares of free trading stock for 60 days media advertisement, web design and maintenance for Power 3 Medical Products Inc. (PWRM.OB)

by: Bill Pennyman
Recognize The Signs Of Prescription Drug Abuse The Emergence Of Traditional Medicine Thrush in Adults - Why You Should Avoid Drugs When Treating Oral Thrush Valid Claims for Medical Malpractice Psoriasis Treatment Emedicine What is pain? Ultram What is pain management? Ultram for you Bankruptcy Medical Los Zetas a Mexican Drug Cartel advancing forward paramilitary forces and combat weapons to positions along the U.S. Mexican border The Popularity Behind Various Medicine Students Versus Drugs: The Good Is Certain To Win. Southern California Drug Rehab Center Tips To Find The Experienced Pennsylvania Medical Malpractice Attorney
print
www.yloan.com guest:  register | login | search IP(216.73.216.23) California / Anaheim Processed in 0.017921 second(s), 7 queries , Gzip enabled , discuz 5.5 through PHP 8.3.9 , debug code: 37 , 4181, 92,
Stock Alert On Pwrm.ob ( Power 3 Medical) Presented By Pennytobuck.com Anaheim